首页> 外文OA文献 >Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial

【2h】

Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial

机译：抗血管生殖 - 幼稚和化疗 - 难治性晚期结直肠癌患者的Regorafenib：IIB审判的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Rachel P. Riechelmann; Luiz S. Leite; Giovanni M. Bariani; Joao Glasberg; Thomas G. Rivelli; Leonardo Gomes da Fonseca; Daniela R. Nebuloni; Maria I. Braghiroli; Marcelo A. Queiroz; Alice M. Isejima; Christian Kappeler; Luciana Kikuchi; Paulo M. Hoff;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Regorafenib in Patients with Antiangiogenic‐Na?ve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial [J] . Riechelmann Rachel P., Leite Luiz S., Bariani Giovanni M., The oncologist . 2019,第9期

机译：抗血管生成-NA'VE和化疗 - 难治性晚期结直肠癌患者的RegoraFenib：IIB审判的结果
2. Regorafenib in Patients with Antiangiogenic-Na?ve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial [J] . Rachel P. Riechelmann, Alice M. Isejima, Christian Kappeler, The oncologist . 2019,第9期

机译：抗血管生成-NA'VE和化疗 - 难治性晚期结直肠癌患者的RegoraFenib：IIB审判的结果
3. A phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma [J] . Sun Weijing, Patel Anuj, Normolle Daniel, Cancer: A Journal of the American Cancer Society . 2019,第6期

机译：中雷达蒽尼作为化疗 - 难治性，先进和转移性胆道腺癌患者的单一药剂的2阶段试验
4. Towards automatic patient selection for chemotherapy in colorectal cancer trials [C] . Alexander Wright, Derek Magee, Philip Quirke, Conference on digital pathology . 2014

机译：在大肠癌试验中寻求化学疗法的自动患者选择
5. Alpha-methylacyl-CoA racemase: A candidate gene for prostate cancer and advanced distal colorectal adenomas in the prostate, lung, colorectal, and ovarian cancer screening trial. [D] . Daugherty, Sarah. 2007

机译：α-甲基酰基辅酶A消旋酶：在前列腺癌，肺癌，结肠直肠癌和卵巢癌筛查试验中，前列腺癌和晚期远端结肠直肠腺瘤的候选基因。
6. Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial [O] . Rachel P. Riechelmann, Luiz S. Leite, Giovanni M. Bariani, 2019

机译：雷戈非尼用于抗血管生成初治和化疗难治性晚期大肠癌的患者：IIb期临床试验的结果
7. A phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma [O] . Weijing Sun, Anuj Patel, Daniel Normolle, 2018

机译：中雷达蒽尼作为化疗 - 难治性，先进和转移性胆道腺癌患者的单一药剂的2阶段试验

Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial

著录项

相似文献

相关主题

期刊订阅